25 results for “Therapeutic Intervention”. Showing 25 of 39,449.
Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease
therapeutic intervention for AD. First, the pathological changes that ultimately
Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention.
therapeutic options. Current treatments are primarily symptomatic and fail to modify disease progression, emphasizing the urgent need for novel, mechanism-based interventions
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
therapeutic intervention is possible in humans. To identify pathways in disease
The Role of PGC1α in Alzheimer's Disease and Therapeutic Interventions.
Therapeutic Interventions. Mota BC(1), Sastre M(1). Author information
Beyond oxidative stress: Ferroptosis as a novel orchestrator in neurodegenerative disorders.
therapeutic intervention, offering hope for disease-modifying strategies. This review
Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.
therapeutic interventions for AD. Future investigations are needed to define
CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review.
therapeutic intervention for AD. Through synthesizing evidence from in vitro
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
therapeutic interventions that could play a crucial role in mitigating
Phosphatase and tensin homolog: A potential target for therapeutic intervention in optic nerve regeneration.
therapeutic interventions in this process. Optic nerve regeneration progresses through
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.
therapeutic interventions for PD possess limited effects and have serious
Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data.
therapeutic intervention in neurodegeneration. The licensed antidepressant trazodone is one drug
CRISPR-Cas9 and next-generation gene editing strategies for therapeutic intervention of neurodegenerative pathways in Alzheimer's disease: a state-of-the-art review.
gene-editing strategies that may redefine therapeutic intervention for AD.
Linkage of circadian rhythm disruptions with Alzheimer's disease and therapeutic interventions.
therapeutic interventions targeting circadian dysfunction. Specifically, it examines the efficacy
tsRNAs: A Prospective, Effective Therapeutic Intervention for Neurodegenerative Diseases.
therapeutic intervention. tsRNAs are emerging as important regulatory molecules in neurodegenerative
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
therapeutic intervention due to the failure of β-amyloid-lowering
The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?
that may work as targets for therapeutic intervention in AD.
Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model.
therapeutic intervention for Alzheimer's disease. Here, we screen a library
Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.
therapeutic interventions. The prion-like propagation of α-synuclein, and the clinical
Network toxicology and cell experiments reveal the mechanism of DEHP-induced diabetic nephropathy via Wnt signaling pathway.
therapeutic intervention. Through comprehensive screening across multiple toxicology and disease
BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis.
therapeutic interventions. Neuroinflammation represents a central pathogenic mechanism in ALS, yet the upstream
BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis.
therapeutic interventions. Neuroinflammation represents a central pathogenic mechanism in ALS, yet the upstream
Stroke Related Brain-Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms.
therapeutic interventions, therapeutic targets remain elusive, necessitating further investigations into
Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.
therapeutic interventions. By delineating therapeutic opportunities and known targets, we seek
Glymphatic System Dysfunction in Alzheimer's Disease: Insights into its Mechanisms, Diagnostic Imaging, and Therapeutic Perspectives: A Systematic Review.
therapeutic interventions. A comprehensive literature search was conducted in PubMed
p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.
therapeutic problem for intervention and management. Current strategies, based on our knowledge